Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 10;16(12):e1002884.
doi: 10.1371/journal.pmed.1002884. eCollection 2019 Dec.

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials

Andrew Vernon  1 , Katherine Fielding  2   3 , Rada Savic  4 , Lori Dodd  5 , Payam Nahid  6
Affiliations

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials

Andrew Vernon et al. PLoS Med. .

Abstract

Andrew Vernon and co-authors discuss adherence to therapy and its measurement in tuberculosis treatment trials.

PubMed Disclaimer

Conflict of interest statement

All the authors work on TB clinical trials; PN, RS, and AV collaborate as part of the TB Trials Consortium, supported by CDC.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tuberculosis Chemotherapy Centre. A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India. Bull World Health Organ. 1959;21(1):51–144. - PMC - PubMed
    1. Fox W. Whither Short Course Chemotherapy. Brit J Dis Chest 1981; 75:331 10.1016/0007-0971(81)90022-x - DOI - PubMed
    1. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999. October;3(10 Suppl 2):S231–79. - PubMed
    1. Lienhardt C, Nahid P. Advances in clinical trial design for development of new TB treatments: A call for innovation. PLoS Med. 2019. March 22; 16(3):e1002769 10.1371/journal.pmed.1002769 - DOI - PMC - PubMed
    1. Kent PW, Fox W, Miller AB, Nunn AJ, Tall R, Mitchison DA. The therapy of pulmonary tuberculosis in Kenya: a comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment services. Tubercle. 1970. March; 51(1):24–38. 10.1016/0041-3879(70)90125-x - DOI - PubMed

Publication types